The new lens will use an embedded microchip to measure blood sugar levels and send the real-time information to a mobile app. The lens is currently expected to be on the market within five years, according to a Business Insider report.
According to Forbes, the lens was developed at the top-secret Google[x] facility, most well-known for building Google’s driverless car and reported to contain some of Google’s top scientists and most innovative products.
The Novartis partnership announcement comes shortly after Google co-founders Sergey Brin and Larry Page said they would limit their foray into the healthcare industry.
“Generally, health is just so heavily regulated,” said Mr. Brin at the annual Khosla Ventures CEO Summit. “It’s just a painful business to be in. It’s just not necessarily how I want to spend my time.”
More Articles on Google:
5 Tips for Social Media Success in Healthcare
Google Offers BAA to Make Gmail, Drive, Calendar HIPAA Compliant
Dignity Health’s Google Glass Success
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.